183 related articles for article (PubMed ID: 30446901)
1. Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy.
Wang PG; Li YT; Pan Y; Gao ZZ; Guan XW; Jia L; Liu FT
J Neurooncol; 2019 Jan; 141(1):71-81. PubMed ID: 30446901
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
Younis SG; Khedr RA; El-Shorbagy SH
J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.
Wang T; Gao T; Niu X; Xing X; Yang Y; Liu Y; Mao Q
World Neurosurg; 2018 Jun; 114():e218-e223. PubMed ID: 29524717
[TBL] [Abstract][Full Text] [Related]
5. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection.
Wang X; Ren H; Zhao T; Chen J; Sun W; Sun Y; Ma W; Wang J; Gao C; Gao S; Lang M; Jia L; Hao J
Carcinogenesis; 2014 Oct; 35(10):2283-90. PubMed ID: 25086759
[TBL] [Abstract][Full Text] [Related]
7. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
[TBL] [Abstract][Full Text] [Related]
8. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
[TBL] [Abstract][Full Text] [Related]
9. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
[TBL] [Abstract][Full Text] [Related]
10. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
[TBL] [Abstract][Full Text] [Related]
11. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
[TBL] [Abstract][Full Text] [Related]
12. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
13. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
Parlato C; Barbarisi M; Moraci M; Moraci A
Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
Chen T; Wang XY; Li C; Xu SJ
Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
[TBL] [Abstract][Full Text] [Related]
16. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
Matsui JK; Allen PK; Perlow HK; Johnson JM; Paulino AC; McAleer MF; Fouladi M; Grosshans DR; Ghia AJ; Li J; Zaky WT; Chintagumpala MM; Palmer JD; McGovern SL
J Neurooncol; 2023 Jul; 163(3):717-726. PubMed ID: 37440097
[TBL] [Abstract][Full Text] [Related]
18. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas.
Quaranta M; Divella R; Daniele A; Di Tardo S; Venneri MT; Lolli I; Troccoli G
Tumori; 2007; 93(3):275-80. PubMed ID: 17679463
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
Topkan E; Besen AA; Ozdemir Y; Kucuk A; Mertsoylu H; Pehlivan B; Selek U
Mediators Inflamm; 2020; 2020():4392189. PubMed ID: 32565725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
